Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Valeant Pharmaceuticals International Inc. (T.BHC) had Income from Continuous Operations of 249.35M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
246.59M |
|
-- |
|
-- |
|
-- |
|
852.73M |
|
-- |
|
300.32M |
|
300.32M |
|
249.35M |
|
|
Income from Continuous Operations |
249.35M |
249.35M |
|
249.35M |
|
852.73M |
|
1.29B |
|
371.30M |
|
375.50M |
|
0.66 |
|
0.66 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
36.95B |
|
-- |
|
-- |
|
-- |
|
36.46B |
|
490.43M |
|
-21.71B |
|
490.43M |
|
370.47M |
|
| Cash Flow Statement Financials | |
1.25B |
|
-431.19M |
|
-698.44M |
|
1.65B |
|
1.85B |
|
191.49M |
|
181.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.30 |
|
-- |
|
-- |
|
0.98 |
|
59.11 |
|
72.03% |
|
23.09% |
|
23.09% |
|
-- |
|
8.13% |
|
6.68% |
|
826.56M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.47 |
|
1.11 |
|
81.14 |
|
50.84% |
|
-1.15% |
|
0.67% |
|
0.87% |
|
1.32 |
|
2.20 |
|
3.32 |
|